InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,265.81
(
-0.33%
)
US TECH 100
18,076.00
(
-0.27%
)
Dow Jones
38,539.82
(
-0.08%
)
Brent Oil
77.51
(
-0.81%
)
Bitcoin
70,023.92
(
1.77%
)
Post# of 3884
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DorseyE

Send PM Follow Ignore
Followers 8
Posts 2087
Boards Moderated 0
Alias Born 08/09/2003

DorseyE

Re: DorseyE post# 2653

Monday, 01/04/2021 11:28:17 AM

Monday, January 04, 2021 11:28:17 AM

Post# of 3884
Another pearl in the article.......
Notably, apart from COVID-19, opaganib is being evaluated in a phase IIa study for treating advanced cholangiocarcinoma and in a phase II study for addressing prostate cancer.

Seems the market isn’t listening at the moment.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent RDHL News
More RDHL News
InvestorsHub NewsWire

FEATURED Element79 Gold Corp Continues Fostering Local Community Engagement • Jun 4, 2024 9:08 AM

PickleJar Debuts Nationwide Contest With Brian Kelley for Fans to Win a Three-Day Bahama Cruise • NREG • Jun 3, 2024 8:45 AM

ILUS Provides an Update on the Binding Term Sheet Signed with Actelis Networks (NASDAQ: ASNS) • ILUS • May 31, 2024 12:52 PM

Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • ELEM • May 30, 2024 1:18 PM

Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM

ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM

Start posting your company's news
Only $200 per official company press release!